MCT-475

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMCT-475
Drug Alias NameIgP therapeuticIg-NPMCT-475MCT-485
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionToll like receptor 8 agonistsAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsImmunostimulants +[10] 
TargetsToll like receptor 8Toll like receptor 3Tumor necrosis factor α +[5] 
Therapy Area/IndicationsHepatitis, ChronicLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMulticell Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMulticell Technologies
Active IndicationsN/A
Inactive IndicationsHepatitis, ChronicLiver Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A